Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José L Molinuevo

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Revista Espanola De Geriatria Y Gerontologia|December 14, 2011
[Role of biomarkers in the early diagnosis of Alzheimer's disease]José L Molinuevo Guix
International Psychogeriatrics|September 30, 2005
Regulatory issuesJosé L Molinuevo, Rafael Blesa
The Medical Clinics of North America|May 7, 2013
Applying the IWG research criteria in clinical practice: feasibility and ethical issuesJosé L Molinuevo, Lorena Rami
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's diseaseSerge Gauthier, José L Molinuevo
Revista De Neurologia|January 12, 2012
[Assessment of the strategies to improve therapeutic compliance in routine clinical practice in noncompliant patients with Alzheimer-type dementia]José L Molinuevo, Francisco J Arranz
Journal of Alzheimer'S Disease : JAD|October 24, 2013
Clinical profile of Alzheimer's disease: is the age of the patient a decisive factor? Results of the INFLUENCE studyJosé L Molinuevo, Ignacio Casado-Naranjo
Medicina Clinica|June 9, 2006
[Genetics of prevalent neurodegenerative disorders]Albert Lladó, Carles Gaig, José L Molinuevo
American Journal of Alzheimer'S Disease and Other Dementias|April 23, 2005
Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementiasJosé L Molinuevo, Albert Lladó, Lorena Rami
American Journal of Alzheimer'S Disease and Other Dementias|March 9, 2004
Memantine: an antiglutamatergic option for dementiaJosé L Molinuevo, Vicente Garcia-Gil, Amparo Villar
The Medical Clinics of North America|May 7, 2013
International Work Group criteria for the diagnosis of Alzheimer diseaseJeffrey L Cummings, Bruno Dubois, José L Molinuevo, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Revista Espanola De Geriatria Y Gerontologia|December 14, 2011
[Role of biomarkers in the early diagnosis of Alzheimer's disease]José L Molinuevo Guix
International Psychogeriatrics|September 30, 2005
Regulatory issuesJosé L Molinuevo, Rafael Blesa
The Medical Clinics of North America|May 7, 2013
Applying the IWG research criteria in clinical practice: feasibility and ethical issuesJosé L Molinuevo, Lorena Rami
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's diseaseSerge Gauthier, José L Molinuevo
Revista De Neurologia|January 12, 2012
[Assessment of the strategies to improve therapeutic compliance in routine clinical practice in noncompliant patients with Alzheimer-type dementia]José L Molinuevo, Francisco J Arranz
Journal of Alzheimer'S Disease : JAD|October 24, 2013
Clinical profile of Alzheimer's disease: is the age of the patient a decisive factor? Results of the INFLUENCE studyJosé L Molinuevo, Ignacio Casado-Naranjo
Medicina Clinica|June 9, 2006
[Genetics of prevalent neurodegenerative disorders]Albert Lladó, Carles Gaig, José L Molinuevo
American Journal of Alzheimer'S Disease and Other Dementias|April 23, 2005
Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementiasJosé L Molinuevo, Albert Lladó, Lorena Rami
American Journal of Alzheimer'S Disease and Other Dementias|March 9, 2004
Memantine: an antiglutamatergic option for dementiaJosé L Molinuevo, Vicente Garcia-Gil, Amparo Villar
The Medical Clinics of North America|May 7, 2013
International Work Group criteria for the diagnosis of Alzheimer diseaseJeffrey L Cummings, Bruno Dubois, José L Molinuevo, et al.
Pageof 8